Pfizer settles with Teva, Sun over Protonix
Pfizer Inc. has agreed to a $2.15 billion patent infringement settlement with Teva Pharmaceuticals Industries Ltd. and Sun Pharmaceutical Industries Ltd. for their launches of generic Protonix in the United States.